transplantologiyaТрансплантологияTransplantologiya. The Russian Journal of Transplantation2074-05062542-0909IPO Association of Transplantologiststransplantologiya-120Research ArticleАКТУАЛЬНЫЕ ВОПРОСЫ ТРАНСПЛАНТОЛОГИИACTUAL ISSUES OF TRANSPLANTATIONПрофилактика грибковой инфекции в раннем послеоперационном периоде после трансплантации печениPrevention of fungal infection in the early period after liver transplantationХубутияМ. Ш.KhubutiyaM. Sh.ЖуравельС. В.Zhuravel'S. V.zhsergey5@gmail.comЧерненькаяТ. В.Chernen'kayaT. V.ОспановаГ. К.OspanovaG. K.БаженовА. И.BazhenovA. I.КузнецоваН. К.KuznetsovaN. K.УткинаИ. И.UtkinaI. I.ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ», МоскваРоссияN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, MoscowRussian Federation201606062016022934Copyright © Хубутия М.Ш., Журавель С.В., Черненькая Т.В., Оспанова Г.К., Баженов А.И., Кузнецова Н.К., Уткина И.И., 20162016Хубутия М.Ш., Журавель С.В., Черненькая Т.В., Оспанова Г.К., Баженов А.И., Кузнецова Н.К., Уткина И.И.Khubutiya M.S., Zhuravel' S.V., Chernen'kaya T.V., Ospanova G.K., Bazhenov A.I., Kuznetsova N.K., Utkina I.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jtransplantologiya.ru/jour/article/view/120

В статье рассмотрены риск и частота развития грибковых инфекций в раннем периоде послеортотопической трансплантации печени, их диагностика, лечение и профилактика. Пациенты после трансплантации печени имеют высокий риск развития инвазивной грибковой инфекции. Наличие факторов высокого риска является абсолютным показателем для профилактического назначения противогрибковых лекарственных средств.

This article describes the risk and incidence of fungal infections in the early period after liver transplantation, their diagnosis, treatment and prevention. After liver transplant patients have a higher risk of developing invasive fungal infection. The presence of high - risk factors is an absolute indication for prophylactic antifungal medicine.

трансплантация печенигрибковые инфекциипротивогрибковая терапияliver transplantationfungal infectionsantifungal therapyReferencesBacterial infections in the early period after liver transplantation: etiological agents and their susceptibility / D. Kawecki, A. Chmura, M. Pacholczyk [et al.] // Med. Sci. Monit. – 2009. – Vol. 15, N. 12. – CR628–CR637.Kawecki D., Chmura A., Pacholczyk M., et al. Bacterial infections in the early period after liver transplantation: etiological agents and their susceptibility. Med Sci Monit. 2009; 15 (12): CR628– CR637.Liver transplantation complications in the intensive care unit and at 6 months / E. Tenza, C.G. Bernardo, D. Escudero [et al.] // Transplant. Proc. – 2009. – Vol. 41, N. 3. – P. 1050–1053.Tenza E., Bernardo C.G., Escudero D., et al. Liver transplantation complications in the intensive care unit and at 6 months. Transplant Proc. 2009; 41 (3): 1050– 1053.Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study / K.D. Watt, R.A. Pedersen, W.K. Kremers [et al.] // Am. J. Transplant. – 2010. – Vol. 10, N. 6. – P. 1420–1427.Watt K.D., Pedersen R.A., Kremers W.K., et al. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK longterm follow-up study. Am J Transplant. 2010; 10 (6): 1420–1427.Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients / D. Neofytos, J.A. Fishman, D. Horn [et al.] // Transpl. Infect. Dis. – 2010. – Vol. 12, N. 3. – P. 220–229.Neofytos D., Fishman J.A., Horn D., et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010; 12 (3): 220–229.Singh, N. Fungal infections in the recipients of solid organ transplantation / N. Singh // Infect. Dis. Clin. North Am. – 2003. – Vol. 17, N. 1. – P. 113–134.Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003; 17 (1): 113–134.Septic shock attributed to Candida infection: importance of empiric therapy and source control / M. Kollef, S. Micek, N. Hampton [et al.] // Clin. Infect. Dis. – 2012. – Vol. 54, N. 12. – P. 1739–1746.Kollef M., Micek S., Hampton N., et al. Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Infect Dis. 2012; 54 (12): 1739–1746.Person, A.K. Fungal infections in transplant and oncology patients / A.K. Person, D.P. Kontoyiannis, B.D. Alexander // Infect. Dis. Clin. North Am. – 2010. – Vol. 24, N. 2. – P. 439–459.Person A.K., Kontoyiannis D.P., Alexander B.D. Fungal infections in transplant and oncology patients. Infect Dis Clin North Am. 2010; 24 (2): 439–459.Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis / M. Cruciani, C. Mengoli, M. Malena [et al.] // Liver Transpl. – 2006. – Vol. 12, N. 5. – P. 850–858.Cruciani M., Mengoli C., Malena M., et al. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 2006; 12 (5): 850–858.Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry / D.L. Horn, D. Neofytos, E.J. Anaissie [et al.] // Clin. Infect. Dis. – 2009. – Vol. 48, N. 12. – P. 1695–1703.Horn D.L., Neofytos D., Anaissie E.J., et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009; 48 (12): 1695–1703.Outcomes of antifungal prophylaxis in high-risk liver transplant recipients / S. Hadley, C. Huckabee, P.G. Pappas [et al.] // Transpl. Infect. Dis. – 2009. – Vol. 11, N. 1. – P. 40–48.Hadley S., Huckabee C., Pappas P.G., et al. Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis. 2009; 11 (1): 40–48.Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients / J. Fortún, P. Martín-Dávila, M. Montejo [et al.] // Transplantation. – 2009. – Vol. 87, N. 3. – P. 424–435.Fortún J., Martín–Dávila P., Montejo M., et al. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation. 2009; 87 (3): 424–435.Журавель, С.В. Проблема системного кандидоза после трансплантации солидных органов / С.В. Журавель, А.О. Чугунов, Т.В. Черненькая // Трансплантология. – 2012. – № 3. – C. 42–48.Zhuravel' S.V., Chugunov A.O., Chernen'kaya T.V. Problema sistemnogo kandidoza posle transplantatsii solidnykh organov [The problem is systemic candidiasis after transplantation of solid organs]. Transplantologiya. 2012; 3: 42–48. (In Russian).Risk factors for invasive fungal infections complicating orthotopic liver transplantation / L.A. Collins, M.H. Samore, M.S. Roberts [et al.] // J. Infect. Dis. – 1994. – Vol. 170, N. 3. – P. 644–652.Collins L.A., Samore M.H., Roberts M.S., et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994; 170 (3): 644–652.Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study / M.D. Sharpe, C. Ghent, D. Grant [et al.] // Transplantation. – 2003. – Vol. 76, N. 6. – P. 977–983.Sharpe M.D., Ghent C., Grant D., et al. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation. 2003; 76 (6): 977–983.Candida albicans arteritis transmitted by preservation fluid after liver transplantation / P. Addeo, A.C. Saouli, M.L. Woehl-Jaegle [et al.] // Ann. Transplant. – 2014. – Vol. 19. – P. 64–67.Addeo P., Saouli A.C., Woehl-Jaegle M.L., et al. Candida albicans arteritis transmitted by preservation fluid after liver transplantation. Ann Transplant. 2014; 19: 64–67.Curtis, L. Better hospital nutrition needed to reduce morbidity and mortality from fungal infections / L. Curtis // Crit. Care Med. – 2010. – Vol. 38, N. 12. – P. 2428–2429.Curtis L. Better hospital nutrition needed to reduce morbidity and mortality from fungal infections. Crit Care Med. 2010; 38 (12): 2428–2429.Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET) / P.G. Pappas, B.D. Alexander, D.R. Andes [et al.] // Clin. Infect. Dis. – 2010. – Vol. 50, N. 8. – P. 1101–1111.Pappas P.G., Alexander B.D., Andes D.R., et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010; 50 (8): 1101–1111.Fishman, J.A. Infection in solid-organ transplant recipients / J.A. Fishman // N. Engl. J. Med. – 2007. – Vol. 357, N. 25. – P. 2601–2614.Fishman J.A. Infection in solid–organ transplant recipients. N Engl J Med. 2007; 357 (25): 2601–2614.Диагностика и лечение микозов в отделениях реанимации и интенсивной терапии. Российские национальные рекомендации / под ред. Н.Н. Климко. – М.: БОРГЕС, 2010. – 87 с.Klimko N.N., ed. Diagnostika i lechenie mikozov v otdeleniyakh reanimatsii i intensivnoy terapii. Rossiyskie natsional'nye rekomendatsii [Diagnosis and treatment of fungal infections in the intensive care unit. Russian national recommendations]. Moscow: BORGES Publ., 2010. 87 p. (In Russian).Shoham, S. Invasive fungal infections in solid organ transplant recipients / S. Shoham, K. Marr // Future Microbiol. – 2012. – Vol. 7, N. 5. – P. 639–655.Shoham S., Marr K. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012; 7 (5): 639–655.

The authors declare that there are no conflicts of interest present.